Rabaca, Candelaria A.
HRN: 26-02-57 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/13/2024
ACICLOVIR 800MG (TAB)
10/13/2024
10/20/2024
ORAL
800mg
Q4
Varicella Zoster Infection
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes